Stock Price Quote

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.

NSE : NABSE : 524663ISIN CODE : INE994B01014Industry : Pharmaceuticals & DrugsHouse : PSU
BSE31.67-0.86 (-2.64 %)
PREV CLOSE ( ) 32.53
OPEN PRICE ( ) 32.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 114357
TODAY'S LOW / HIGH ( )31.00 32.99
52 WK LOW / HIGH ( ) 20.543.89
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 10-03 1989
Management Info
Sudhanshu Vrati - Chairman Dhananjay Kumar Tiwary - Managing Director
Registered Office

Address Village Chola Dist,, ,
Bulandshahar,
Uttar Pradesh-203203

Phone 9458096110

Email sklalacs@yahoo.co.in

Website www.bibcol.com

Registrars Details
MAS Services Ltd
T-34 , 2nd Floor,Okhla Industrial Area,Phase - II,New Delhi
Listing : BSE, Delhi, U.P.

NEWS

01Feb Bharat Immunologicals & Biologicals Co
Pursuant to the Regulation 29 and other applicable Regulation(s) of Secu..
06Oct Bharat Immunologicals & Biologicals Co
Bharat Immunologicals & Biologicals Corporation has informed that pu..
03Aug Bharat Immunologicals & Biologicals Co
Pursuant to the Regulation 29 and other applicable Regulation(s) of Secu..
30Oct Bharat Immunological And Biological Co
In pursuance of the LODR with Stock Exchange, Bharat Immunological And B..
04Dec Bharat Immunologicals & Biologicals Co
In compliance with the provision of LODR, 2015, Bharat Immunologicals &a..

Financials

in Millions
QTR Sep 23 ANNUAL 23
Net Profit-49.17-170.56
Gross Profit -66.45 -228.51
Operating Profit -45.24-156.64
Net Sales 446.09

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Pfizer (BSE)
peergroup  4569.90 (4.30%)
M.Cap ( in Cr)20906.26
Neuland Laboratories (BSE)
peergroup  7102.20 (0.54%)
M.Cap ( in Cr)9112.04
Bajaj Healthcare (BSE)
peergroup  356.30 (11.20%)
M.Cap ( in Cr)983.33
Caplin Point Lab (BSE)
peergroup  1452.35 (1.89%)
M.Cap ( in Cr)11029.40
Jenburkt Pharma (BSE)
peergroup  787.20 (3.23%)
M.Cap ( in Cr)347.41

Shareholding Pattern

PROMOTERS 59.25%
NON-INSTITUTION 40.75%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Bharat Immunologicals & Biologicals Corporation Ltd.

Bharat Immunologicals & Biologicals Corporation Ltd. was incorporated in the year 1989. Its today's share price is 31.67. Its current market capitalisation stands at Rs 136.75 Cr. In the latest quarter, company has reported Gross Sales of Rs. 446.09 Cr and Total Income of Rs.456.69 Cr. The company's management includes Dhananjay Kumar Tiwary, Sandip Kumar Lal, Pankaj Kumar, Mohd Aslam, Madhu Dikshit, Alka Sharma, Sudhanshu Vrati.

It is listed on the BSE with a BSE Code of 524663 , NSE with an NSE Symbol of and ISIN of INE994B01014. It's Registered office is at Village Chola Dist,, Bulandshahar-203203, Uttar Pradesh. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BK Kapur & Co, Hari & Associates, Rasool Singhal & Co, Reshma & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.